Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EXOTIC: Elixirium thymi compositum for acute bronchitis in pediatric patients
2025-520845-61-00Phase 4Authorised
- Sponsor
- Semmelweis University
- Start
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in acute bronchitis comparing Elixirium thymi compositum FoNo VIII with Placebo (2 arms). Primary endpoint: Efficacy based on Bronchitis Severity Score. Planned start May 2025; status: authorised.
02
Drugs
Elixirium thymi compositum FoNo VIII
03
Conditions
acute bronchitis
Beyond the preview
Go deeper on 2025-520845-61-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2025-520845-61-00.